Roundhill Cannabis ETF (BATS: WEED) Momentum Soars to 89.25 Amid Federal Reform Optimism
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6d ago
0mins
Source: Benzinga
- Surging Momentum: The Roundhill Cannabis ETF's momentum score has surged to 89.25, placing it in the 89th percentile among industry peers, significantly outperforming Aurora Cannabis's score of 21.25, indicating strong investor confidence amid federal cannabis reform optimism.
- Short-Term Strength: While the ETF has shown a robust short-term performance with a 61.50% increase over the last six months, the medium-term trend remains negative, suggesting that investors should prepare for volatility and a multi-stage adjustment process.
- Policy Catalyst: President Trump's push to reschedule cannabis to Schedule 3 is viewed as the most significant federal policy shift in 50 years, which could eliminate the burdensome Section 280E tax, greatly enhancing the profitability of U.S. operators.
- 2026 Performance Decline: Despite the strong momentum, the Roundhill ETF has declined by 4.72% in 2026 so far, closing at $19.38 on Tuesday, reflecting short-term market uncertainty and volatility.
Analyst Views on ACB
Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is 4.32 USD with a low forecast of 4.32 USD and a high forecast of 4.32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 4.320
Low
4.32
Averages
4.32
High
4.32
Current: 4.320
Low
4.32
Averages
4.32
High
4.32
No data
About ACB
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
